Molecular Biology Structural Biology
Influence of MIF, EPHX2, and BCHE gene polymorphisms on multiple sclerosis susceptibility and clinical severity
Abstract
Background and aim Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system (CNS) with a global prevalence of 23.9 cases per 100,000 population. The present study was conducted to assess the impact of MIF, EPHX2, and BCHE SNPs on MS pathogenesis and prognosis. Methods This case-control study was undertaken in collaboration with the Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Menoufia University, and the Faculty of Applied Health Sciences Technology, Menoufia University. Participants were categorized into two groups. • Group 1: Patients diagnosed with multiple sclerosis (MS). • Group 2: healthy controls matched for age, gender, and socioeconomic position, with no history of neurological or autoimmune disorders. Results It was found that MIF (GC + CC) and EPHX2 (AG + GG) genotypes pushed the risk up sharply, by 600% and 338.3% respectively. From multivariate analysis, MIF (GC + CC) and EPHX2 (AG + GG) were found to be independent predictors of MS. The BCHE TT genotype did not reach significance for disease onset but was significantly linked to a worse clinical course. In contrast, each unit rise in RBC reduced MS risk by 71.3%, and vitamin D by 29.5%. Conclusion MIF (GC + CC) and EPHX2 (AG + GG) variants are associated with MS susceptibility, while the BCHE TT genotype trended with severity, while vitamin D and red blood cells have shown a protective effect, highlighting biological pathways for future study.